amrinone has been researched along with Infant, Premature, Diseases in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walker, PC | 1 |
| Perry, BL | 1 |
| Shankaran, S | 1 |
1 other study available for amrinone and Infant, Premature, Diseases
| Article | Year |
|---|---|
Safety of amrinone for treating congestive heart failure in a premature neonate.
Topics: Amrinone; Heart Failure; Humans; Infant, Newborn; Infant, Premature, Diseases; Male | 1987 |